Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Ironwood Pharma (IRWD) Reports Q2 Loss Per Share of 34c, Offers Guidance
August 5, 2015 4:23 PM EDTIronwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.34), may not compare to the analyst estimate of ($0.22). Revenue for the quarter came in at $27.7 million versus the consensus estimate of $36.53 million.
2015 Financial Guidance.
Ironwood continues to expect its 2015 total operating expenses to... More
